Opportunity Information: Apply for CDC RFA GH13 135504CONT16
Apply for CDC RFA GH13 135504CONT16
- A new public funding opportunity ""HIV Care and Treatment Services in the Dukwi Refugee Camp – Botswana under the President’s Emergency Plan for AIDS Relief (PEPFAR)”" is now available to receive applications.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "HIV Care and Treatment Services in the Dukwi Refugee Camp - Botswana under the President's Emergency Plan for AIDS Relief (PEPFAR)" focuses on expanding and sustaining comprehensive HIV services for refugees and other camp-connected populations living in and around Dukwi Refugee Camp in Botswana. It is positioned under PEPFAR, the United States government's flagship initiative to address the global HIV epidemic, and it is associated with the U.S. Centers for Disease Control and Prevention (CDC), specifically the Center for Global Health (CGH) and the Division of Global HIV and TB (DGHT) in Botswana. In practical terms, the award is meant to ensure that people living with HIV in a humanitarian setting can access the same quality of testing, treatment, and prevention services that are expected in stable, national health systems, while also addressing camp-specific barriers like mobility, stigma, legal and documentation concerns, and limited on-site clinical capacity.
At its core, the opportunity is about delivering the full continuum of HIV care and treatment in a refugee camp environment, which typically includes HIV testing services and case finding, rapid linkage to care, initiation and maintenance of antiretroviral therapy (ART), and long-term retention support so patients stay on treatment and remain virally suppressed. The implementing partner is generally expected to support clinical services that align with Botswana national HIV guidelines and PEPFAR technical standards, including baseline and follow-up monitoring, management of opportunistic infections and common co-morbidities, and adherence counseling tailored to the realities of displaced populations. A strong emphasis in PEPFAR-funded treatment programs is usually placed on viral load monitoring and achieving viral suppression at population level, so activities often include ensuring access to lab services, timely result return, and clinical action on unsuppressed viral load results through enhanced adherence counseling and appropriate regimen changes when indicated.
Because Dukwi is a refugee camp, the scope commonly extends beyond routine facility-based services to include outreach and community-based approaches that identify people who are not in care, re-engage those who have fallen out of care, and provide differentiated service delivery options. That can mean multi-month dispensing of ART when feasible, support for stable patients through less frequent visits, and targeted support for people at higher risk of treatment interruption, such as new arrivals, people with uncertain legal status, adolescents and young adults, and individuals facing language or cultural barriers. Programs in camp settings often also need to be prepared for movement into and out of the camp, so continuity of care, transfer documentation, and coordination with surrounding health facilities become important operational elements.
Prevention and public health components are also typically embedded in this kind of opportunity, particularly those that reduce onward transmission and support PEPFAR epidemic control goals. This often includes prevention counseling, condom availability and risk-reduction services, HIV testing for partners and family members, and integration of sexual and reproductive health where appropriate. If prevention of mother-to-child transmission (PMTCT) services are relevant to the camp population, the partner may be expected to ensure that pregnant and breastfeeding women living with HIV are identified early, started or maintained on effective ART, and supported to remain in care, alongside infant prophylaxis, early infant diagnosis, and follow-up for HIV-exposed infants. Given the vulnerability profile of many displaced communities, programs may also incorporate targeted work for adolescents, survivors of sexual violence, and other groups facing heightened risk, with strong referral pathways for clinical care, psychosocial support, and protection services.
An important part of PEPFAR-funded service delivery is health systems strengthening and quality improvement, and that matters even more in a setting like Dukwi where services may rely on a combination of camp-based clinics, district health structures, and partner-supported staff. The award commonly expects the recipient to build or reinforce clinical and program management capacity, including training and mentorship for healthcare workers, implementation of standard operating procedures, and ongoing quality improvement cycles that track performance and address gaps in care. Infection prevention and control, pharmacy and supply chain management for uninterrupted ART availability, and strengthening of patient flow and appointment systems are common operational needs. Data systems and monitoring are also central, since PEPFAR requires routine reporting on testing, treatment, retention, and viral load outcomes; in a camp setting this also means maintaining confidential records while ensuring data can be aggregated and aligned with national reporting systems.
Coordination is typically a defining feature of this opportunity. Effective implementation in Dukwi generally requires close collaboration with the Government of Botswana health authorities, camp administration, and humanitarian stakeholders, as well as alignment with national HIV program policies and PEPFAR strategies in-country. Because refugees may face unique access and protection issues, coordination with agencies involved in refugee protection and services is often necessary to reduce barriers to care and ensure that service delivery does not inadvertently increase stigma or risk for clients. The program design often needs to show clear referral networks for services not provided on-site, such as advanced clinical management, TB diagnostic services, maternal and child health services, mental health care, and specialized laboratory testing, along with mechanisms to follow up referrals and confirm that clients actually receive the services.
Overall, the opportunity is structured to support a capable implementing organization that can deliver high-quality HIV clinical services in a humanitarian context while meeting PEPFAR expectations for measurable outcomes, accountability, and continuous improvement. The intended end results usually include increased identification of people living with HIV in the camp community, faster linkage and ART initiation, higher retention in care, improved adherence support, and high rates of viral suppression, alongside strengthened systems for supply continuity, workforce capacity, and reliable program data. In short, it is a targeted PEPFAR award aimed at ensuring refugees in Dukwi have consistent, effective HIV care and treatment services that are comparable in quality to national services, despite the challenges that come with displacement and camp-based living.
If you share the full source notice (or paste the "complete source data" section), the summary can be tightened further to include the specific eligibility rules, anticipated funding amount, period of performance, required activities and deliverables, and any special evaluation or reporting requirements stated in the announcement.
Frequently Asked Questions (FAQs)
1) What is the purpose of this grant opportunity?
This opportunity supports the expansion and long-term sustainability of comprehensive HIV care and treatment services for refugees and other camp-connected populations living in and around Dukwi Refugee Camp in Botswana. The intent is to make sure people living with HIV in a humanitarian setting can access high-quality services comparable to those available in stable national health systems, while addressing camp-specific barriers such as mobility, stigma, documentation concerns, and limited on-site clinical capacity.
2) What is the official title of the opportunity?
The opportunity is titled "HIV Care and Treatment Services in the Dukwi Refugee Camp - Botswana under the President's Emergency Plan for AIDS Relief (PEPFAR)."
3) Who is the funding initiative behind this award?
The award is positioned under PEPFAR, the United States government initiative focused on addressing the global HIV epidemic.
4) Which U.S. agency is associated with the opportunity?
The opportunity is associated with the U.S. Centers for Disease Control and Prevention (CDC), specifically the Center for Global Health (CGH) and the Division of Global HIV and TB (DGHT) in Botswana.
5) Where will the supported activities take place?
Activities are focused on Dukwi Refugee Camp in Botswana and, as described, may include refugees and other populations connected to the camp living in and around the camp area.
6) Who is intended to benefit from the funded services?
The primary intended beneficiaries are people living with HIV within the Dukwi Refugee Camp context, including refugees and other camp-connected populations. The scope also commonly includes partners and families who may need testing and prevention services, and potentially pregnant and breastfeeding women and HIV-exposed infants if PMTCT needs are present.
7) What does "comprehensive HIV care and treatment" mean in this context?
It generally refers to the full continuum of services: HIV testing and case finding, rapid linkage to care, initiation and maintenance of antiretroviral therapy (ART), routine monitoring and clinical follow-up, management of opportunistic infections and common co-morbidities, adherence counseling, retention support, and viral load monitoring with clinical response for unsuppressed results.
8) Is HIV testing part of the expected scope?
Yes. The description highlights HIV testing services, case finding, and identifying people who are not yet in care as core parts of the continuum in a camp environment.
9) How important is rapid linkage to care and ART initiation?
Rapid linkage and faster ART initiation are described as intended end results. Programs are expected to help people move quickly from diagnosis to enrollment in care and starting or continuing effective ART.
10) What clinical standards or guidelines should services align with?
Clinical services are generally expected to align with Botswana national HIV guidelines and PEPFAR technical standards, including expectations for monitoring, adherence support, and quality of care.
11) What role does viral load monitoring play in the program?
Viral load monitoring is emphasized as a key component of PEPFAR-funded treatment programs. The scope often includes ensuring access to lab services, timely return of results, and clinical action when viral load is unsuppressed (for example, enhanced adherence counseling and regimen changes when indicated).
12) What is meant by "retention support" in a refugee camp setting?
Retention support refers to helping patients stay engaged in care and continue ART over time. In a camp setting, this can include follow-up systems, appointment support, tailored adherence counseling, and approaches designed to prevent treatment interruptions caused by mobility, stigma, or other access barriers.
13) Are community outreach and community-based approaches expected?
Yes. The description notes that camp settings often require outreach and community-based strategies to identify people not in care, re-engage those who have fallen out of care, and reduce access barriers that limit use of facility-based services alone.
14) What is "differentiated service delivery" and how might it apply here?
Differentiated service delivery generally means tailoring how services are delivered based on client needs and stability on treatment. Examples mentioned include multi-month dispensing of ART when feasible, less frequent visits for stable patients, and more targeted support for people at higher risk of treatment interruption.
15) Which groups may need additional or targeted support under this award?
The description highlights groups commonly at higher risk of interruption or barriers to care in camp settings, including new arrivals, people with uncertain legal status, adolescents and young adults, and individuals facing language or cultural barriers. It also references support needs for survivors of sexual violence and other groups facing heightened risk.
16) How does the program address movement into and out of the camp?
Continuity of care is described as important due to mobility. Operational elements may include transfer documentation, coordination with surrounding health facilities, and systems to help clients continue treatment if they move.
17) Are prevention services included, or is this only about treatment?
Prevention and public health components are described as typically embedded. These may include prevention counseling, condom availability and risk-reduction services, partner and family testing, and integration with sexual and reproductive health where appropriate.
18) Does the opportunity include prevention of mother-to-child transmission (PMTCT)?
PMTCT is described as potentially relevant depending on the camp population. If applicable, expected elements may include identifying pregnant and breastfeeding women living with HIV early, supporting effective ART and retention, infant prophylaxis, early infant diagnosis, and follow-up for HIV-exposed infants.
19) What kinds of referral networks are expected?
The program design often needs clear referral networks for services not provided on-site. Examples mentioned include advanced clinical management, TB diagnostic services, maternal and child health services, mental health care, and specialized laboratory testing, along with mechanisms to follow up referrals and confirm service receipt.
20) How does health systems strengthening fit into this award?
Health systems strengthening and quality improvement are described as important components, especially in a camp setting where services may depend on camp clinics, district structures, and partner-supported staff. The recipient is commonly expected to strengthen capacity through training, mentorship, standard operating procedures, and quality improvement cycles.
21) What operational areas may the implementing partner need to strengthen?
Common operational needs described include infection prevention and control, pharmacy and supply chain management to avoid ART stockouts, patient flow and appointment systems, and building workforce and program management capacity.
22) What data and reporting expectations are implied by PEPFAR?
Routine monitoring and reporting are central. PEPFAR requires regular reporting on key outcomes such as testing, treatment, retention, and viral load. In a camp setting, this also includes maintaining confidential records while ensuring data can be aggregated and aligned with national reporting systems.
23) How are confidentiality and protection considerations addressed in a refugee camp context?
The description notes the need to maintain confidential records and to coordinate in ways that reduce barriers and avoid increasing stigma or risk for clients. It also references legal and documentation concerns as a camp-specific barrier that programs may need to navigate through appropriate coordination.
24) What coordination is typically required to implement this program effectively?
Close collaboration is typically required with the Government of Botswana health authorities, camp administration, and humanitarian stakeholders, while aligning services with national HIV policies and PEPFAR strategies. Coordination with refugee protection and service agencies may also be necessary to reduce access barriers and protect clients.
25) What are the main outcomes the award is trying to achieve?
Intended end results include increased identification of people living with HIV in the camp community, faster linkage and ART initiation, higher retention in care, improved adherence support, and high rates of viral suppression. The opportunity also aims to strengthen systems such as supply continuity, workforce capacity, and reliable program data.
26) Does this opportunity specify eligibility, funding amount, or period of performance?
Those details are not provided in the information shared here. The description indicates that if the full source notice is provided, the summary could be tightened to include eligibility rules, anticipated funding amount, period of performance, required deliverables, and evaluation/reporting requirements.
27) What additional details would help clarify application requirements?
The full source notice (including any "complete source data" section) would help identify specific eligibility criteria, the anticipated award size, performance period, required activities and deliverables, and any special evaluation or reporting requirements.
Browse more opportunities from the same agency: HHS-CDC
Browse more opportunities from the same category: Health
Next opportunity: Intermountain West Joint Venture Operations and Administration
Previous opportunity: BLM Nevada 2017 Challenge Cost Share Program All projects
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 135504CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 135504CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| State-Based Perinatal Quality Collaboratives Apply for CDC RFA DP14 140403CONT16 Funding Number: CDC RFA DP14 140403CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| “Reducing the Burden of Neglected Parasitic Infections (NPIs) in the United States through Evidence-Based Prevention and Control Activities” Apply for CDC RFA GH15 161702CONT16 Funding Number: CDC RFA GH15 161702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Small Business Alzheimer's Disease Research (R41/R42) Apply for PA 16 092 Funding Number: PA 16 092 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| USAID/Indonesia - Maternal and Newborn Health Activity Apply for RFI 497 16 00001 Funding Number: RFI 497 16 00001 Agency: USAID-IND Category: Health Funding Amount: Case Dependent |
| Small Business Alzheimer's Disease Research (R43/R44) Apply for PA 16 091 Funding Number: PA 16 091 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Grants to Expand Substance Abuse Treatment Capacity in Adult Treatment Drug Courts and Adult Tribal Healing to Wellness Courts (Short Title: SAMHSA Treatment Drug Courts) Apply for TI 16 009 Funding Number: TI 16 009 Agency: HHS-SAMHS Category: Health Funding Amount: $325,000 |
| Service Area Competition – Additional Areas (SAC-AA) – California, Hawaii, New York, Oregon, and Washington Apply for HRSA 16 181 Funding Number: HRSA 16 181 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Strengthening Human Resources for Health through Increased Capacity of the Ethiopian Medical Association in the Federal Democratic Republic of Ethiopia under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 121705CONT16 Funding Number: CDC RFA GH12 121705CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening Local Ownership for the Sustainable Provision of HIV/AIDS Services in the Health Bureaus of Southern Nations, Nationalities and Peoples Apply for CDC RFA GH12 122205CONT16 Funding Number: CDC RFA GH12 122205CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening Capacity for Laboratory Systems, Strategic Information, and Technical Leadership in Public Health for the National HIV/AIDS Response in the Federal Democratic Republic of Ethiopia under the President’s Emergency Plan for AIDS Relief ( Apply for CDC RFA GH13 131304CONT16 Funding Number: CDC RFA GH13 131304CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| “Strengthening Local Ownership for the Sustainable Provision of Comprehensive HIV/AIDS Services by the Health Bureaus of Amhara and Tigray Regional States of the Federal Democratic Republic of Ethiopia under the President’s Emergency Plan for AID Apply for CDC RFA GH13 131104CONT16 Funding Number: CDC RFA GH13 131104CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with Egypt Ministry of Health and Population for Global Disease Detection Activities Apply for CDC RFA GH13 136904CONT16 Funding Number: CDC RFA GH13 136904CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R01) Apply for RFA NS 16 021 Funding Number: RFA NS 16 021 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Consortium for Food Allergy Research: Leadership Center (UM2) Apply for RFA AI 15 050 Funding Number: RFA AI 15 050 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Sudden Unexpected Infant Death Case Registry: Building Capacity (Module A) and Implementation (Module B) Apply for CDC RFA DP15 150602CONT16 Funding Number: CDC RFA DP15 150602CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Consortium for Food Allergy Research: Clinical Research Units (UM1) Apply for RFA AI 15 051 Funding Number: RFA AI 15 051 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| The National Syndromic Surveillance Program: Enhancing Syndromic Surveillance Capacity and Practice Apply for CDC RFA OE15 150202CONT16 Funding Number: CDC RFA OE15 150202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement on Occupational Health with the World Health Organization (WHO): Implementing World Health Assembly Resolution 60.26 ‘Global Plan of Action for Workers’ Health 2008-2017’ Apply for RFA OH 14 00203CONT16 Funding Number: RFA OH 14 00203CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Targets of Low Dose Alcohol in the Brain (R01) Apply for RFA AA 16 008 Funding Number: RFA AA 16 008 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Pakistan FELTP-Human/Animal Disease Investigation and Technical Assistance to the Pakistan Ministry of Health and Ministry of Agriculture, Center for Global Health Apply for CDC RFA GH15 162002CONT16 Funding Number: CDC RFA GH15 162002CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 135504CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
